Ohglip MP 2mg/500mg/15mg Tablet
Marketer
Orenburg Healthcare Pvt. Ltd.
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Ohglip MP 2mg/500mg/15mg Tablet
Metformin/Pioglitazone/Voglibose combination tablets (2mg/500mg/15mg) manage blood glucose in adults with type 2 diabetes. Used alongside diet and exercise, this medication enhances insulin effectiveness, reducing blood sugar. Dosage and duration should strictly follow your physician's instructions. Take with food to minimize stomach discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose; never double the dose. High doses risk hypoglycemia (low blood sugar). Concurrent use with other diabetes medications, alcohol, or skipped meals increases hypoglycemia risk; regular blood sugar monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Patients with kidney, liver, or heart conditions, and pregnant or breastfeeding individuals, must consult their doctor before use. Kidney function tests will be performed prior to treatment initiation. Limit alcohol consumption due to increased side effect risk.
Primary Ingredients of Ohglip MP 2mg/500mg/15mg Tablet
No information provided. A rephrased version cannot be created.
Uses of Ohglip MP 2mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Ohglip MP 2mg/500mg/15mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Ohglip MP 2mg/500mg/15mg Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
Common Side effects of Ohglip MP 2mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Ohglip MP 2mg/500mg/15mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Ohglip MP 2mg/500mg/15mg Tablet should be administered with a meal.
How Ohglip MP 2mg/500mg/15mg Tablet works:
Ohglip MP 2mg/500mg/15mg tablets contain glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. Their combined action improves blood sugar management when single or dual medication proves inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Ohglip MP 2mg/500mg/15mg Tablets is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Using Ohglip MP 2mg/500mg/15mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any hazards before prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Ohglip MP 2mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Scant available evidence in humans indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar irregularities.
KidneyCAUTION
Caution is advised when prescribing Ohglip MP 2mg/500mg/15mg tablets to individuals with impaired kidney function; dosage modification may be necessary. Patients with severe kidney disease should not take Ohglip MP 2mg/500mg/15mg tablets. Regular monitoring of renal function is recommended during treatment. A physician's consultation is recommended.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Ohglip MP 2mg/500mg/15mg tablets, as dosage modification may be necessary. Medical advice is recommended. The use of Ohglip MP 2mg/500mg/15mg tablets is contraindicated in patients with severe liver dysfunction.
What if you forget to take Ohglip MP 2mg/500mg/15mg Tablet :
Should you forget to take your Ohglip MP 2mg/500mg/15mg Tablet, administer it immediately upon recollection. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Ohglip MP 2mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently